Contract facts
Federal8507610281 - INCREMENTAL FUNDS OPTION PERIOD 1 - CLIN 1003 FUNDED THROUGH 2/28/22, CLIN 1011 FULLY FUNDED, CLIN 1012 FULLY FUNDED, CLIN 1013 FULLY FUNDED, CLIN 1014 FULLY FUNDED, CLIN 1017 FULLY FUNDED, is a federal award for Dcso Philadelphia held by Leidos Innovations Corp. Estimated value $58.7M ($28M obligated). Current period of performance ends Feb 14, 2024. Last award drew 1 bidder. Place of performance: GAITHERSBURG MD. Related solicitation SP470920Q1030.
8507610281 - INCREMENTAL FUNDS OPTION PERIOD 1 - CLIN 1003 FUNDED THROUGH 2/28/22, CLIN 1011 FULLY FUNDED, CLIN 1012 FULLY FUNDED, CLIN 1013 FULLY FUNDED, CLIN 1014 FULLY FUNDED, CLIN 1017 FULLY FUNDED,
Recompete timing
PublicCurrent PoP ended Feb 14, 2024 (956 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Want the durability read on SP470920F0078? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordLeidos Innovations Corp — $2.9B obligated across 148 awards (firm-wide, all agencies) · lead buyer Department of Transportation (DOT).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract SP470920F0078?
SP470920F0078 (8507610281 - incremental FUNDS OPTION PERIOD) is a Dcso Philadelphia award with a potential value of $58.7M, currently held by Leidos Innovations Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is SP4709-20-F-0078?
SP4709-20-F-0078 is the dashed form of PIID SP470920F0078 (8507610281 - incremental FUNDS OPTION PERIOD), held by Leidos Innovations Corp. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded SP470920F0078?
Dcso Philadelphia awarded SP470920F0078 to Leidos Innovations Corp (potential $58.7M).
Who is the incumbent on SP470920F0078?
Leidos Innovations Corp is the incumbent with $2.9B across 148 related awards in SCOUT’s public footprint. The current period of performance ends Feb 14, 2024.
When does Leidos Innovations Corp’s SP470920F0078 come up for recompete?
SCOUT tracks a period-of-performance end of Feb 14, 2024. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on SP470920F0078? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Buy one Pursuit Analysis — $500Credits toward the Sprint Pack
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.